title: Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Greece: A Cost-Effectiveness and Cost-Utility Analysis.
authors.affiliation: National School of Public Health, Athens, Greece.
authors.forename: K
authors.initials: K
authors.lastname: Athanasakis
authors.affiliation: National School of Public Health, Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Karampli
authors.affiliation: National School of Public Health, Athens, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Ollandezos
authors.affiliation: National School of Public Health, Athens, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Igoumenidis
authors.affiliation: GlaxoSmithKline, Halandri, Greece.
authors.forename: P
authors.initials: P
authors.lastname: Karabela
authors.affiliation: GlaxoSmithKline, Halandri, Greece.
authors.forename: D
authors.initials: D
authors.lastname: Psomali
authors.affiliation: National School of Public Health, Athens, Greece.
authors.forename: J
authors.initials: J
authors.lastname: Kyriopoulos